Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Deferasirox tablets bulk supplier for pharma manufacturers

Deferasirox Tablets 125 mg, 250 mg, and 500 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 125 mg, 250 mg, and 500 mg

Reference Brands: Exjade(Dispersible tablets);Jadenu (Film-coated Tablet)s

Category: Blood Disorder

Deferasirox 125 mg, 250 mg and 500 mg dispersible tablets, an oral iron chelator for transfusional iron overload, for importers, distributors, haematology units and thalassaemia programmes.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Deferasirox Tablets? List it or send an offer →

Product Description:

Deferasirox is an oral iron chelator: two molecules bind one iron atom in a stable complex excreted mainly in the faeces. The 125 mg, 250 mg and 500 mg strengths on this page belong to the dispersible tablet, stirred into water, orange juice or apple juice and drunk at once. A later film-coated tablet uses different strengths at lower doses because exposure is higher. The forms are not interchangeable milligram for milligram. The dispersible form suits children and anyone who cannot swallow tablets.

It is used for chronic iron overload from repeated transfusions, as in beta-thalassaemia major and sickle cell disease, and in some labels for non-transfusion-dependent thalassaemia. It is taken once daily by weight, on an empty stomach at least 30 minutes before food. Serum ferritin is checked monthly to guide dosing. Kidney, liver and blood tests are monitored because renal and hepatic impairment and gastrointestinal bleeding can occur, and hearing and eyes are checked. Aluminium antacids are avoided, and rifampicin reduces exposure.

Sourcing notes. Deferasirox is prescription-only, and each form needs its own bioequivalence data and dossier, so state dispersible or film-coated in your enquiry. Ask for the CTD or ACTD file with dissolution and dispersion-time data and zone IVb stability for hot, humid markets. Blisters are kept at room temperature, away from moisture. Request a CoA per batch with assay, impurity and dispersion results, the GMP certificate and a CoPP. Thalassaemia programmes order for months ahead, so state pack size and remaining shelf life.

Deferasirox Tablets — third party manufacturing & bulk supply

Deferasirox Tablets 125 mg, 250 mg, and 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Deferasirox Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Deferasirox Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Deferasirox Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Deferasirox tablets is listed as Tablet in 125 mg, 250 mg, and 500 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Deferasirox tablets is referenced against Exjade(Dispersible tablets);Jadenu (Film-coated Tablet)s. Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Deferiprone Tablets

Strength:
250 mg, 500 mg

Form: Tablet

Reference Brands: Ferriprox(US)

View Details
Daunorubicin Injection

Strength:
20 mg/mL

Form: Intravenous (IV) injection:

Reference Brands: Cerubidine(US)

View Details
Deferoxamine Injection

Strength:
500 mg/mL

Form: Injection

Reference Brands: Desferal(US)

View Details
Cytarabine IV/SQ/Intrathecal Injection

Strength:
100 mg/mL(IV & SQ); 50 mg/mL(intrathecal use)

Form: Injection

Reference Brands: -

View Details
Filgrastim Injection (Subcutaneous and IV)

Strength:
300 million IU

Form: Injection (Subcutaneous and IV)

Reference Brands: Neupogen (US)

View Details
Pegfilgrastim Injection

Strength:
6 mg per single-use syringe

Form: Injection

Reference Brands: Neulasta (US)

View Details
Leucovorin Calcium Tablets

Strength:
5 mg, 10 mg, 15 mg, 25 mg

Form: Tablets

Reference Brands: Wellcovorin

View Details
Mesna Injection

Strength:
100 mg/mL

Form: Injection

Reference Brands: Mesnex(US)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us